Unable to load price data. Sorry.

¯\_(ツ)_/¯

Emisphere Technologies, Inc. (NASDAQ OTHER:EMIS)

CAPS Rating: 1 out of 5

A biopharmaceutical company specializing in the oral delivery of therapeutic macromolecules and other compounds that are poorly deliverable by oral means.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQ OTHER:EMIS will perform against the market?

Add Stock to CAPS Watchlist

All Players

51 Outperform
52 Underperform
 

All-Star Players

8 Outperform
28 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top NASDAQ OTHER:EMIS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

rajny (< 20)
Submitted October 21, 2010

I can't argue with the thumbs-down pitches. This stock has held promise and has disappointed for years.However, if someone is looking for a high-risk, potentially high reward stock, EMIS is the biotech to look at...especially because it has been… More

TSIF (99.98)
Submitted February 11, 2019

May have some potential working with Novo Nordisk on applying their technology to oral insulin, but the low overhead from the (six) cited employees is being offset by the very high debt load. Data/Filings look stale, but last posted they had a neg… More

NASDAQ OTHER:EMIS VS S&P 500 (SPY)

Fools bullish on NASDAQ OTHER:EMIS are also bullish on:

Fools bearish on NASDAQ OTHER:EMIS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EMIS.

Recs

0
Member Avatar OklaBoston (41.99) Submitted: 4/3/2019 8:54:59 PM : Outperform Start Price: $6.20 NASDAQ OTHER:EMIS Score: +29.75

First profitable Quarter in the stock's history last year.

Recs

0
Member Avatar kdakota630 (29.35) Submitted: 2/22/2019 10:32:37 AM : Underperform Start Price: $3.05 NASDAQ OTHER:EMIS Score: -156.90

Whoa, Nellie, not so fast fella. No way! Back to reality. Not a good pick. Not now. Wrong logic at this point. Gravity calls. Watch out on this one. Not at all optimistic. Pessimism reigns. Downward trend continues. Likely to continue to underperform. Look out below. More downside imminent. Danger danger, at least for the next month. So obvious.

Recs

2
Member Avatar TSIF (99.98) Submitted: 2/11/2019 1:17:18 PM : Underperform Start Price: $3.40 NASDAQ OTHER:EMIS Score: -130.86

May have some potential working with Novo Nordisk on applying their technology to oral insulin, but the low overhead from the (six) cited employees is being offset by the very high debt load.
Data/Filings look stale, but last posted they had a
neg -155M in book, they aren't worth a $200M Market cap.

OTC company.

Target 20+ points

Leaderboard

Find the members with the highest scoring picks in EMIS.

Score Leader

MATTEH

MATTEH (84.37) Score: +476.60

The Score Leader is the player with the highest score across all their picks in EMIS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
MATTEH 84.37 9/20/2010 Outperform 5Y $1.10 +629.09% +152.49% +476.60 0 Comment
rajny < 20 10/19/2010 Outperform 5Y $1.17 +585.47% +143.45% +442.02 1 Comment
runway2 < 20 3/21/2011 Outperform 1Y $1.60 +401.25% +120.97% +280.28 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. DesiCluB90 54.01 11/15/2010 Outperform 5Y $1.72 +366.28% +137.83% +228.45 0 Comment
FRESHTASTIC 43.51 11/8/2010 Outperform 5Y $1.95 +311.28% +134.41% +176.87 1 Comment
DeerHunter73 72.40 12/3/2010 Outperform 3Y $2.05 +291.22% +134.80% +156.42 0 Comment
Pilarchard 96.36 10/23/2006 Underperform 5Y $9.98 -19.64% +121.69% +141.33 0 Comment
astrodogind 91.15 10/16/2006 Underperform 5Y $9.66 -16.98% +122.98% +139.95 4 Comments
brokenradio 22.30 11/26/2010 Outperform 1Y $2.22 +261.42% +140.53% +120.90 0 Comment
Tgconner1983 < 20 1/6/2011 Outperform 5Y $2.37 +238.40% +124.59% +113.81 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackIcahn 84.59 8/27/2008 Outperform 1Y $3.85 +108.31% +131.98% -23.67 1 Comment
TrackMatrix < 20 9/1/2006 Underperform NS $8.30 -95.78% +5.87% +101.65 4/17/2012 @ $0.35 0 Comment

Advertisement